Position in CRMD
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$254,176
-$1,349,949 QoQ
Shares Held
37,434
-72.9% QoQ
Ownership
0.048%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in CRMD Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $1,494,072,071 across 362 Biotechnology names. CRMD ranks #200 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
663,263 | $296,173,457 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
313,093 | $241,908,173 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
220,623 | $72,997,531 | |
| 4 | MRNA |
Moderna, Inc.
|
932,269 | $47,359,264 | |
| 5 | INSM |
INSMED Inc
|
275,731 | $45,087,531 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,415,848 | $39,218,988 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
383,179 | $37,264,156 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
669,601 | $35,301,364 |
All Filings in CRMD
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $254,176 | 37,434 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,604,125 | 137,930 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,518,075 | 130,531 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $1,792,866 | 145,525 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $540,792 | 87,791 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $855,376 | 105,602 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $629,189 | 77,870 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $701,425 | 161,992 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $770,611 | 181,748 | Shares | Sole | 2026-03-24 | |
| 2023-12-31 | $822,108 | 218,646 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $563,613 | 152,328 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $603,622 | 152,046 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $676,985 | 163,523 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $604,017 | 143,132 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $405,063 | 143,132 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $3,015,000 | 750,000 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $33,723 | 6,154 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $209,281 | 45,996 | Shares | Sole | 2022-02-23 | |
| 2021-09-30 | $72,014 | 15,487 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $131,540 | 19,175 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $271,957 | 27,223 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $76,120 | 10,245 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $83,865 | 13,908 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $89,352 | 14,183 | Shares | Sole | 2020-08-12 | |
| 2020-03-31 | $30,392 | 8,466 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||